Clinical Role - Retail
Pharmacy Times® is the most trusted resource as it pertains to providing the latest industry news and information to retail pharmacists and reaches more than 200,000 total pharmacy professionals.
Pharmacy Hero: Pharmacist Coordinates Schedule to Protect Immunocompromised Staff Members During COVID-19 Pandemic
“What she did for me this week is what defines heroic.”
Week in Review: Pharmaceutical Companies Lend Support to Hydroxychloroquine Clinical Trials for COVID-19
Top news of the week from Pharmacy Times surrounding the novel coronavirus.
New data from the FAIR Health white paper show that from 2017 to 2018, telehealth use grew 12% and use of retail clinics grew 10%.
Gunda Siska, PharmD, explains potential vitamins to keep patients healthy.
In addition, RUCDR has submitted an emergency use authorization request for a saliva collection method that will allow for broader population screening.
Camber Pharmaceuticals has announced that it has added Glycerin Liquid and 3 syrups to their increasingly diverse portfolio: Simple Syrup, Cherry Syrup and SoSweet® Syrup.
The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
The USP has developed an online toolkit using guidelines from major public health organizations.
Today we’re celebrating the work of Mayank Amin, PharmD, RPh, MBA, owner of Skippack Pharmacy.
Pharmacists push against state-level limits on dispensing of hydroxychloroquine for coronavirus disease 2019.
One of the critical barriers surrounding the coronavirus disease 2019 (COVID-19) pandemic is the lack of access to testing, specifically among high-risk populations.
More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what physicians typically recommend for chronic pain relief via data from clinical studies, according to research published in PLOS ONE.